Oral vs. injectable semaglutide: what is the difference?

Oral vs. injectable semaglutide: what is the difference?

The short answer: Injectable semaglutide (Wegovy) leads to greater weight loss on average than the oral tablet (Rybelsus), but the latter is a perfectly valid option for those who wish to avoid injections. Your doctor will decide which form is best suited for you.

Semaglutide is available in two forms: as a weekly injection (Wegovy) and as a daily tablet (Rybelsus). Both suppress appetite through the same mechanism, but they differ significantly in how they are absorbed by the body, their effectiveness for weight loss, and their practical pros and cons. This article explains what semaglutide (Ozempic) is, how these two dosage forms differ, and what choice Goodweigh will make together with you.

What is the difference between oral and injectable semaglutide?

The main technical difference relates to how the medication is absorbed into the body. The bioavailability of subcutaneous semaglutide is approximately 89%, meaning that almost the entire dose reaches the bloodstream. The situation is quite different for the tablet form: the bioavailability is only 1–2%, and for a small group of patients, it is practically zero. According to the "Farmacotherapeutisch Kompas," absorption is so unpredictable that oral GLP-1 agonists are not recommended over subcutaneous preparations, especially in patients with a high risk of cardiovascular disease.

To compensate for this poor absorption, Rybelsus (oral semaglutide) contains the excipient SNAC, which facilitates absorption through the stomach wall. However, this only works under strict conditions: the tablet must be taken on an empty stomach with no more than 120 ml of water, and you must wait at least 30 minutes before eating, drinking, or taking other medications. These restrictions do not apply to the injectable preparation.

Rybelsus is approved for the treatment of type 2 diabetes, not primarily for weight loss. Only high-dose injectable semaglutide (Wegovy 2.4 mg/week) has received official approval for the treatment of obesity and overweight in adults. This difference also affects reimbursement: the purpose for which you use semaglutide determines whether the medication is covered.

Which form of medication is most effective for weight loss?

Injectable semaglutide leads to greater weight loss on average, although the difference is not as significant as you might think. A large phase 3 study showsthat 25 mg of oral semaglutide led to an average weight loss of 13.6% in overweight individuals over 68 weeks. This is an impressive result. However, a meta-analysis of 12 randomized trials (n = 6,253) shows that injectable semaglutide leads to an average of 2.19 kg more weight loss than the oral medication. How much weight you can lose with semaglutidealso depends heavily on your starting weight, your lifestyle, and how carefully you follow the treatment instructions.

Below is a summary of the key differences.

Oral semaglutide vs. injectable semaglutide: a summary

At the current stage of research, the injectable form is clearly the preferred option when the goal is to achieve maximum efficacy. However, oral semaglutide produces significantly better results than a placebo and subcutaneous liraglutide: The PIONEER 4 study showsthat a 14 mg dose of oral semaglutide led to a 4.4 kg weight loss, while subcutaneous liraglutide resulted in a 3.1 kg weight loss.

What are the benefits of the tablet form?

The biggest advantage is practical: no needles, no fear of injections, and no need to store a pen in the refrigerator. For those who absolutely refuse injections, Rybelsus (oral semaglutide) is a serious option to consider. The tablet is also easier to incorporate into a morning routine without medical assistance.

In addition, some are already achieving excellent results with the tablet. Recently studied higher doses (25 mg) indicate that the gap compared to the injection narrows as the dose increases. For individuals who are slightly overweight or obese, the tablet may be sufficient to reach their weight loss goal.

What are the benefits of the injection?

Wegovy (high-dose semaglutide injection) offers a significantly more predictable effect. Its high bioavailability (~89%) means that the active ingredient is absorbed into the body consistently, regardless of meal times or other medications being used. This also makes it easier for the attending physician to optimize the dosage.

Furthermore, Wegovy is the only semaglutide product shown to reduce the risk of cardiovascular disease in the context of obesity, as demonstrated in the SELECT study. Real-world research showsthat treatment adherence after 18 months is 84% for injectable semaglutide, compared to only 46% for the oral version. This significant difference in adherence has a decisive impact on long-term overall results.

A weekly injection also requires less daily discipline than a tablet, the efficacy of which depends on the timing of administration and fasting state. Patients who make the injection easier by linking it to a specific day of the week generally find the practical burden to be minimal.

Do the side effects differ between oral and injectable semaglutide?

The side effects are largely the same. Both forms of the medication cause gastrointestinal issues, such as nausea, diarrhea, vomiting, and constipation, especially during the dose escalation phase. Serious but rare side effects, such as acute pancreatitis and kidney failure, occur with both forms. For a comprehensive overview, read about the side effects of semaglutide.

However, there are two significant differences. The tablet more frequently causes local gastrointestinal issues because the active ingredient is absorbed in the stomach rather than under the skin, and higher doses of Rybelsus are more often associated with taste disturbances (dysgeusia). For some users, the injection causes a reaction at the injection site, such as redness or mild swelling. A 12-month study shows that injectable semaglutide leads to greater weight loss, especially in men, which indirectly affects the side effect profile at higher doses.

What does Goodweigh offer?

Goodweigh provides you with medical support throughout your semaglutide treatment via an online consultation with one of our doctors. The doctor will recommend the most suitable form of administration for you, taking into account your health status, preferences, and weight goals. Therefore, it is always assessed on a case-by-case basis whether a tablet or an injection is the best choice for you.

After the initial discussion, Goodweigh handles the prescriptions, and the medication is delivered discreetly to your home. Throughout the treatment, you will be in contact with your doctor: the gradual increase of the dose and any potential side effects are also monitored so that you are never left on your own. A 12-month study showsthat treatment support and consistency are decisive factors in final weight loss, regardless of which form of semaglutide you use.

The right form of semaglutide for you: decided together with Goodweigh

Semaglutide, whether oral or injectable, has proven its effectiveness in weight loss. The injection provides better results on average and ensures better long-term treatment adherence. The tablet is a perfectly valid option for those who do not wish to use injections, provided that the dosage instructions are followed strictly. By discussing it with a doctor, you will decide which form suits you best. Request your first consultation via Goodweigh and begin your weight loss journey in a medically responsible way.